Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Thielmann

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapyPhilipp Jansen, Wolfgang Galetzka, Carl M Thielmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2021
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphologyAnne Zaremba, Georg Lodde, Rajmohan Murali, et al.
European Heart Journal|February 9, 2022
Impact of myocardial injury after coronary artery bypass grafting on long-term prognosisL Pölzl, M Thielmann, S Cymorek, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapyCarl M Thielmann, Johanna Matull, Anne Zaremba, et al.
Der Anaesthesist|September 30, 2020
[Short version of the 2nd edition of the German-Austrian S3 guidelines "Cardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment"]K Werdan, U Boeken, M J Briegel, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2021
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitorsCarl M Thielmann, Eleftheria Chorti, Johanna Matull, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatmentGeorg C Lodde, Philipp Jansen, Inga Möller, et al.
International Journal of Cardiology|July 16, 2014
Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis, D A Healy, W A Khan, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
pTERT mutational status is associated with survival in stage IV melanoma patients receiving first-line immune therapyPhilipp Jansen, Wolfgang Galetzka, Carl M Thielmann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2021
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphologyAnne Zaremba, Georg Lodde, Rajmohan Murali, et al.
European Heart Journal|February 9, 2022
Impact of myocardial injury after coronary artery bypass grafting on long-term prognosisL Pölzl, M Thielmann, S Cymorek, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Association of antibiotic treatment with survival outcomes in treatment-naïve melanoma patients receiving immune checkpoint blockadeEleftheria Chorti, Bernd Kowall, Jessica C Hassel, et al.
European Journal of Cancer (Oxford, England : 1990)|December 22, 2021
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapyCarl M Thielmann, Johanna Matull, Anne Zaremba, et al.
Der Anaesthesist|September 30, 2020
[Short version of the 2nd edition of the German-Austrian S3 guidelines "Cardiogenic shock complicating myocardial infarction-Diagnosis, monitoring and treatment"]K Werdan, U Boeken, M J Briegel, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2021
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitorsCarl M Thielmann, Eleftheria Chorti, Johanna Matull, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2022
Genetic characterization of advanced conjunctival melanoma and response to systemic treatmentGeorg C Lodde, Philipp Jansen, Inga Möller, et al.
International Journal of Cardiology|July 16, 2014
Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis, D A Healy, W A Khan, et al.
Pageof 3